Form 4 for MRVI MARAVAI LIFESCIENCES HOLDINGS, INC.

Accepted 2022-01-27 00:00:00 ET · period of report 2022-01-25 · accession 0000899243-22-003418 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DM	2022-01-27	2021-04-30+	MRVI	Herde Kevin	CFO	A - Grant	$22.95	+20.4K	889	New	+$467.9K
D	2022-01-27	2022-01-25	MRVI	Herde Kevin	CFO	A - Grant	$0.00	+36.2K	36.2K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2022-01-25	A	A	19,500	—	20,389	D	—	—	(F2) Represents restricted stock units ("RSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting, subject to the Reporting Person's continued employment with the Issuer. The RSUs will vest in 1/3rd increments on each of February 15, 2023, February 15, 2024, and February 15, 2025, subject to the reporting person's continued employment with the Issuer.
2	Common	Class A Common Stock	2021-04-30	A	A	497	$22.95	497	D	—	—
3	Common	Class A Common Stock	2021-10-31	A	A	392	$22.95	889	D	—	—
4	Derivative	Employee Stock Option (Right to Buy)	2022-01-25	A	A	36,200	$0.00	36,200	D	$26.32 · — to 2032-01-25	36,200 Class A Common Stock	(F3) Represents options awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. These options will vest 1/48th on March 15, 2022 and in equal 1/48th installments each month thereafter, subject to the Reporting Person's continued employment with the Issuer.